PharmaceuticalsOperations

How STADA Uses Celonis to Cut Batch Release Throughput Time by 44%

STADA Arzneimittel AG, the German pharmaceutical company, deployed the Celonis Platform to digitize and automate its batch release process — the final quality approval step before medicines reach the market. The implementation cut throughput time by 44%, improved on-time batch releases by 20%, and eliminated manual spreadsheet operations in favor of a real-time digital dashboard used by 100+ employees daily.

Impact

44%

Reduction in batch release throughput time

20%

Improvement in on-time batch releases

100+

Daily active users

Challenge

STADA's batch release process — the final quality approval before medicines ship — was fragmented across departments with disconnected documentation systems, manual handoffs, and no real-time visibility, causing bottlenecks and delays that slowed medicines from reaching patients.

Solution

STADA deployed the Celonis Platform to create a process mining digital twin of its batch release workflow, replacing manual spreadsheet coordination with automated notifications, unified data management, and a real-time digital dashboard that enables 100+ employees to collaborate across departments on a single view of batch status.

Tools & Technologies

What Leaders Say

We managed to shift from a manually fragmented process to a digital twin of this process. All manual steps have been eliminated and we have over 100 users working together daily.

Vladimir Grad, Center of Excellence Director, STADA

Now with Celonis, we have a full digital dashboard with real-time insight into various parameters, and we can organize our processes and resources to release our product faster to patients.

Monica Aragoneses, Cluster Quality Head, STADA
Get the full context.

Sign up to read complete case studies, access detailed metrics, and unlock all use cases.

Full Story

STADA Arzneimittel AG manufactures branded and generic pharmaceuticals distributed globally. The batch release process — the critical final quality approval that must occur before any medicine can leave the facility — was fragmented across multiple departments with disconnected documentation systems. Each batch required coordination between quality assurance, manufacturing, and regulatory teams, but without a unified workflow these handoffs relied on manual processes and spreadsheets. The result was poor visibility into where each batch stood, bottlenecks that were difficult to diagnose, and delays in getting medicines to patients.

The challenge was structural: because the batch release process touched multiple departments and systems, no single team had a complete picture of the end-to-end workflow. Information gathering was manual and time-consuming, notifications were inconsistent, and there was no real-time view of throughput or on-time performance.

STADA implemented the Celonis Platform to create a process mining digital twin of the entire batch release workflow. All manual steps were mapped, bottlenecks were identified, and automated notifications replaced manual handoffs. A unified digital dashboard now gives quality and operations teams real-time insight into batch status, resource utilization, and release timelines. Over 100 users across departments collaborate on the process daily through the Celonis interface.

The results directly impact patient access to medicines. Throughput time for batch release dropped 44%. On-time batch releases improved 20%. Manual spreadsheet-based operations were eliminated entirely. Vladimir Grad, Center of Excellence Director, described the transformation as a shift from a fragmented manual process to a fully digital workflow — one that gives all stakeholders the same real-time picture and enables them to act proactively rather than reactively.

Similar Cases

P
Pfizer
93%
database reduction

Pfizer achieved a 93% database reduction and 20% cost avoidance by migrating their global SAP environment to S/4HANA on IBM Power10 infrastructure.

PharmaceuticalsTechnologyICIBM ConsultingIPIBM Power Virtual Server
M
Moderna
80
qubits utilized in simulation

Moderna partnered with IBM Quantum to explore quantum computing for mRNA sequence optimization, achieving record-breaking simulations of 60 nucleotide sequences on 80 qubits and advancing toward practical quantum advantage in drug development.

PharmaceuticalsIQIBM Quantum
E
EVERSANA
30 minutes
campaign development time

EVERSANA built the first AI-powered marketing agency platform on Google Cloud using three master AI agents that create complete pharma campaigns in 30 minutes.

PharmaceuticalsGVGoogle Vertex AIGGGoogle Gemini
BG
Bayer GBS
70%
reduction in manual errors

Bayer Global Business Services (GBS) is the shared-services arm of Bayer, one of the world’s largest life sciences companies with 93,000 employees and €46.6 billion in annual sales. The GBS Intelligent Automation team deployed UiPath robotic process automation to handle purchase requisition-to-purchase order workflows globally, eliminating the manual SAP data entry and vendor verification that plagued procurement teams. The result: manual errors fell 70%, vendor and pricing discrepancies dropped 60%, and purchase order creation time shrank from 10 minutes to 3.

PharmaceuticalsUPUiPath Platform
I
IQVIA
40%
reduction in shared service center operating cost

IQVIA, the global healthcare data and analytics company with 80,000 employees and $14B in annual revenue, deployed Celonis’ Execution Management System across its Shared Service Center to eliminate process inefficiencies in Order-to-Cash and Procure-to-Pay. Within two years, the initiative reduced Shared Service Center operating costs by 40%, freed up $600,000 in working capital immediately, and generated millions in cumulative savings.

PharmaceuticalsCCelonis
NN
Novo Nordisk
10 weeks → 10 minutes
clinical study report creation time

Novo Nordisk built NovoScribe using Claude Code to automate clinical study report generation, cutting documentation time from 10+ weeks to 10 minutes.

PharmaceuticalsMAMongoDB AtlasCCClaude Code
C
CSL
Minutes
application discovery time

CSL is a global biotechnology company with 29,000 employees producing life-saving medicines across hemophilia, immunology, vaccines, and nephrology therapies in more than 100 countries. Facing 5,000 VMware servers and 1,000+ applications across 29 data centers accumulated through multiple acquisitions, CSL launched a Technology Modernization Program using AWS. By deploying AWS Transform for VMware — an agentic AI tool for migration wave planning — the company reduced application discovery from hours to minutes and is on track to exit two major data centers by December 2025.

PharmaceuticalsATAWS Transform for VMwareAQAmazon Q Business
D
DSM
Multi-million-dollar
savings from pilot

DSM, the Dutch multinational in health, bioscience, and nutrition, deployed the Celonis Execution Management System to eliminate manual interventions in its Order-to-Cash process. Within a 3-month pilot, the company achieved multi-million-dollar savings, reduced delivery blocks by 10%, improved its APAC first-time-right ratio from 18% to 42%, and grew North America OTIF from 84% to 90%.

ManufacturingCPCelonis Process Intelligence Platform